Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-05

Clinical Trial Update: Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma [NA]

View source ↗

Summary

A terminated clinical trial evaluating the Nanodropper Device for reducing intraocular pressure in glaucoma and ocular hypertension has posted results as of Mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nanodropper Device

Snippet

Sponsor: University of California, San Francisco | Conditions: Glaucoma, Ocular Hypertension | NA | Status: TERMINATED | Results posted: 2026-03-05